Journals Articles about Organ Transplantation

​

1. Talia Novos: Detection of Ganciclovir-Resistant Cytomegalovirus in a Prospective Cohort of Kidney Transplant Recipients Receiving Subtherapeutic Valganciclovir Prophylaxis. Microbiology Spectrum. 10.1128/spectrum.02684-21 (2022).

2. Talia Novos: The importance of Stable Isotope Internal Standards for the LC-MS/MS Analysis of Immunosuppressant Drugs in Whole Blood; Clin Biochem Rev 2014; 35 (4):S51

​

Journal Articles about Early heart attack detection

​

1. Talia Novos: Diagnostic accuracy of High Sensitivity and Point of Care Troponin T Assays in an Emergency Setting. Clin Biochem Rev 2014; 35 (4):S29

2. Talia Novos: Lot-to-Lot Variation of High Sensitivity Troponin T and the Impact on Diagnostic Accuracy. Clin Biochem Rev 2014; 35 (4):S29

​

Drugs in the treatment of Irritable Bowel Disease

​

1. Talia Novos: Analysis of 6-thioguanine (6-tg) and 6-methylmercaptopurine (6-mmp) in whole blood, using online solid phase extraction liquid chromatography tandem mass spectrometry (LC-MS). Clin Biochem Rev 2014; 35 (4):S50

​

Steroid Research

​

1. Talia Novos: Harmonisation of steroid analysis using liquid chromatography mass spectrometry in Australia.  Pathology, 2018; 50: S93. 

 

Tumour Markers

​

1. Talia Novos: Challenging the robustness of plasma Metanephrine methods are laboratories hydrolysing hydrolysing samples for plasma metanephines? 2019. 

2. Talia Novos: Metabolomics in the diagnosis of pheocromocytoma and paraganglioma. Hormone and Metabolic Research. 2018. 

3. Talia Novos: Simultaneous quantification of Homovanillic Avid (HVA), Vanillymandylic acid (VMA) and 5 hydroxy indole acetic acid (5-HIAA) in urine, using online liquid chromatography (LC-MS) tandem mass spectrometry. The Clinical Biochemist Reviews 2013 Sept; 34 (3).

4. Talia Novos: Harmonization of LC-MS/MS measurements of plasma free normetanephrine, metanephrine and 3-methoxytyramine. Clinical Chemistry 2021.

5. Talia Novos: Survey of RCPAQAP Participants regarding their Measurement and Reporting of Plasma Metanephrines. 5th international Symposium on Pheochromocytoma and Paraganglioma 2017.

6. Talia Novos: Target Setting for Urinary Metanephrines in the RCPA Biogenic Amines Program by the advisory Committee on Biogenic Amines. 2017.

7. Talia Novos: Plasma free metanephrines by LC-MSMS: comparison of methods in use across Australia and New Zealand. Clin Biochem Rev, 2015; 36; S1-49.

8. Talia Novos: Measuring tumor succinate and fumarate to resolve pathogenicity of an SDHA variant. Journal of Clinical Chemistry. 2020. 

9. Talia Novos: Aberrant splicing of SDHC in families with unexplained succinate dehydrogenase-deficient paragangliomas. Journal of Endocrine Society. 2020. 

10. Talia Novos: Utility of the succinate:fumarate ratio for assessing SDH dysfunction in different tumor types. Molecular Genetics Metabolism Report. 2017; 10: 45–49.  

11. Talia Novos:  SDHA p.Arg31* is a pathogenic but subpenetrant. 5th international Symposium on Pheochromocytoma and Paraganglioma 2017.

12. Talia Novos: A Novel Liquid Chromatography Mass Spectrometry Method for the Analysis of Succinate: Fumarate Ratios in the Detection of SDHx-associated Tumours. Presented at MSACL, Palm Springs, CA, USA, (Feb, 2016). 

13. Talia Novos: Somatic Fumarate Hydratase (FH) mutation in a paraganglioma. New Horizons combined Health Science Conference, Sydney, New South Wales (Nov, 2015)